Assuming award is required, the following 23 results were found.
-
— March 1, 2024 —Fred Hutchinson Cancer Center announced 12 recipients of the 2024 Harold M. Weintraub Graduate Student Award, which recognizes exceptional achievement in graduate studies in the biological sciences. This year’s recipients come from U.S....
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
of scientists from the U.S. Army Medical Research and Development Command’s Institute of Infectious Diseases a prestigious award from Army Futures Command. The Maj. Gen. Greene Innovation Award recognized USAMRIID’s summary of its development and...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
Platforms for Biodefense and Pandemics.” Since 2002 a highlight of the Bioscience review has been the Clarence A. Broomfield Award lecture, named for one of the institute’s most distinguished scientists and the award’s first recipient. The award...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
Medical Research Institute of Infectious Diseases (USAMRIID), is the recipient of the 2021-2022 Research and Development Award presented by AMSUS, the Society of Federal Health Professionals. Zeng was honored during the AMSUS virtual annual meeting on...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
of death in the United States, with 1 in 5 deaths due to cancer. In announcing the first round of Cancer Moonshot Scholars awards totaling $5.4 million in the first year, the White House said the program seeks to boost the diversity of the applicant...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Medical News
-
within the U.S. Department of Health and Human Services, today announced up to $50 million in funding for six contract awards through the Digital Health Security (DIGIHEALS) project, a digital security project to protect the U.S. health care system's...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
Boosting the effectiveness of CAR T-cell therapies against AML Erik Kimble, MD, received a $100,000 award from the American Society of Gene & Cell Therapy, which will allow him to research improvements to therapies for acute myeloid leukemia (AML). Dr....
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
Spero Therapeutics, Inc. today announced that it was awarded funding of $15.7 million, with the potential for up to an additional $28.5 million over 5 years, from the Biomedical Advanced Research and Development Authority (BARDA). The funding will...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Medical News
-
Upload Step 1A Submission Step 1B: Download NLRA 2023-10 and Required Step 1B Forms (Invitation Only) CASIS will notify all offerors of the review results of their Step 1A: Concept Summary. Download Step 1B Required Forms Step 1B: Technology Roadmap Due...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
a new epidemiological cohort study among Asian Americans, Native Hawaiians and Pacific Islanders (AsA-NHPI). Fred Hutch was awarded a seven-year, $38.7 million National Institutes of Health (NIH) grant to coordinate the effort to gather important health...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
-
Medal of Honor from the French Military Health Service Nov. 11 at a ceremony at the French Embassy in Washington, D.C. The award recognizes his outstanding service to French Armed Forces health protection and his contributions to strengthening...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.